Hematology Risk score Moderate evidence Clinical review pending v1.0.0

PLASMIC Score for Thrombotic Thrombocytopenic Purpura

How likely is severe ADAMTS13 deficiency (TTP) in a patient with thrombotic microangiopathy?

Add to favourites

Calculator

Fields marked * are required. Units can be changed per field.

Reset

Result

Your result will appear here

Complete the inputs and select Calculate. Results update instantly for point scores.

About this tool

Seven-item score predicting severe ADAMTS13 deficiency before results are available.

Intended use

Adults with suspected thrombotic microangiopathy.

Outcome

Severe ADAMTS13 deficiency (activity < 10%)

Time horizon

Current episode

Derivation population

US multi-institutional TMA registry.

Limitations

  • Validated in adults only.
  • Does not replace ADAMTS13 testing.

Clinical problems

Evidence

Evidence level

Moderate evidence

Externally validated, or an established physiological equation whose clinical thresholds rest on consensus; guideline support limited or mixed. Methodology

Evidence summaries for this tool are awaiting independent clinical review. Statistics are shown only where they could be attributed to a specific publication.

References

  1. Original publicationBendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 2017;4:e157-e164. Find on PubMed (opens in a new tab)

Version history

VersionFormulaEffectiveReviewerChanges
v1.0.0Bendapudi 20172026-10-03—Initial implementation with reference test vectors.

Related tools

Clinical decision support only. Interpret results in the context of the individual patient and current guidance; HumanPulse does not replace professional medical judgment.